A Sustainable Future – Water and Energy Conservation in the Pharmaceutical Industry

Related Vendors

EDL Anlagenbau Gesellschaft mbH

Italvacuum, Srl

ProMinent GmbH

Siemens AG

Operating Cost Reduction: Important for Pharmaceutical Industry

Operating cost reduction has become increasingly important for pharmaceutical and virtually every other industry to allow companies to operate as efficiently as possible. Reducing the cost of ownership of a water system is an important aspect of system design. Exploring new methods to reduce the cost of treating water, wastewater discharge, and utility expenses challenges decades-old system designs. Many cost saving techniques can actually offer enhanced reliability and performance of conventional water systems, while lowering cost of ownership.

Achieving regulatory requirements of a water system design usually includes two distinct areas of responsibility in a pharmaceutical application: maintaining minimum water quality standards for discharge or reuse within in the facility and meeting discharge volume from the facility. There are specific contaminant limits on the discharge of water into municipalities or other waste streams.

Exceeding these limits can result in severe financial penalties or put a plant’s operation at risk. In particular, pharmaceutical manufacturers must operate within strict national and local regulatory limits.

Finally, conservation of natural resources and public perception of the pharmaceutical manufacturers is critical for the image of these companies. Companies can receive negative public perception and ratings from regulatory bodies as well as shareholders, if they do not operate at an optimal level. More and more, companies want to be recognised for the efficient use of natural resources and a have gentle global footprint. In addition, companies experience increased scrutiny and pressure from various entities including the public, regarding concerns about pharmaceuticals in drinking water. So, ensuring tight management of water supply is a serious and critical point for pharmaceutical manufacturers – both in the manufacturing process and in product development.

(ID:27333590)